US FDA approves Celcuity's breast cancer drug
14/07/2026 20:25
US FDA approves Celcuity's breast cancer drug July 14 (Reuters) - The U.S. Food and Drug Administration has approved Celcuity's CELC.O drug for an advanced form of breast cancer, the regulator said on Tuesday, making it the company's first product to gain market entry.
(Reporting by Kunal Das and Christy Santhosh in Bengaluru)